There has been much discussion about protracted shortages of critical medicines in the Czech Republic over the last couple of months. Many national measures have been adopted. At the European Union level,the Voluntary Solidarity Mechanism for medicines has been put in place.
PRK Partners Advises Affimed on Divestment of AbCheck
PRK Partners has advised Affimed on its successful divestment of AbCheck to Flagship Pioneering company Ampersand Biomedicines.
Musat & Asociatii Mints Three New Partners and Appoints New Deputy Managing Partner
Dan Minoiu has become a new Deputy Managing Partner at Musat & Asociatii, while Ana Maria Abrudan, Mateea Codreanu, and Stefan Diaconescu have all been promoted to Partner positions.
Wojciech Kulczyk and Krzysztof Sikorski Make Partner at WKB Lawyers
Attorneys-at-Law Wojciech Kulczyk and Krzysztof Sikorski have been elevated to Partner positions with WKB Lawyers at the start of 2024.
Tuca Zbarcea & Asociatii Advises Amethyst Radiotherapy Group on Sale of Buildings to BT Property Alternative REIF
Tuca Zbarcea & Asociatii has advised the Amethyst Radiotherapy Group on the sale and lease-back of three buildings to the BT Property Alternative Real Estate Investment Fund.
Schoenherr Advises Ceres Pharma on Acquisition of Innopharm & VitaPlus in Hungary
Schoenherr has advised Ceres Pharma on the acquisition of the Hungarian pharmaceutical companies VitaPlus and Innopharm, including their Innopharm Austrian subsidiary.
Wolf Theiss Advises QPS Holdings on Sale of QPS Neuropharmacology to Scantox
Wolf Theiss, working with Ropes & Gray, has advised drug development contract research organization QPS Holdings on the full sale of its QPS Neuropharmacology business unit to Scantox. Dorda, working with Denmark's Accura, advised Scantox.